In melanoma, the efficacy of cytotoxic T-lymphocyte associated protein 4 (CTLA-4) blockade has been associated with an increased abundance of Bacteroides thetaiotaomicron and Bacteroides fragilis, which enhance Th1-mediated immune responses [8]. Here, CTLA4 is linked to melanoma.